Stockholder's Equity - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Jul. 31, 2021	May 01, 2020
Preferred Stock [Line Items]
Anti-dilutive securities (in shares)			4,935,804,000
Net proceeds from the issuance of common stock	$ 2,348,201,000	$ 595,313,000	$ 1,056,125,000
Stock Option
Preferred Stock [Line Items]
Anti-dilutive securities (in shares)	5,187,250,000
At The Market Program
Preferred Stock [Line Items]
Authorized amount to sell				$ 2,500,000,000
Remaining amount authorized to sell	$ 1,876,085,000
At The Market Program | Stock Option
Preferred Stock [Line Items]
Net proceeds from the issuance of common stock	$ 435,172,000
Repurchase Program
Preferred Stock [Line Items]
Aggregate amount of common stock offered to sell					$ 1,000,000,000
Shares repurchased during period (in shares)	201,947
Share price (in USD per share)	$ 37.89
Series I Preferred Stock
Preferred Stock [Line Items]
Equivalent number of common stock on conversion of preferred shares (in shares)			0.8857